Showing results (661-670 of 1,810) with videos related to

Sort By:
Pageof 181
Pulmonary Circulation|May 11, 2016
Unexplained exertional dyspnea caused by low ventricular filling pressures: results from clinical invasive cardiopulmonary exercise testingWilliam M Oldham, Gregory D Lewis, Alexander R Opotowsky, et al.
Pulmonary Circulation|May 11, 2016
Pulmonary vascular morphology as an imaging biomarker in chronic thromboembolic pulmonary hypertensionF N Rahaghi, J C Ross, M Agarwal, et al.
Pulmonary Circulation|May 11, 2016
Abnormalities in hyperpolarized (129)Xe magnetic resonance imaging and spectroscopy in two patients with pulmonary vascular diseaseTalal Dahhan, Shiv S Kaushik, Mu He, et al.
Pulmonary Circulation|May 11, 2016
Oral treprostinil for the treatment of pulmonary arterial hypertension in patients transitioned from parenteral or inhaled prostacyclins: case series and treatment protocolJames C Coons, Taylor Miller, Marc A Simon, et al.
Pulmonary Circulation|May 11, 2016
Riociguat (BAY 63-2521) and aspirin: a randomized, pharmacodynamic, and pharmacokinetic interaction studyReiner Frey, Michael Reber, Jörn Krätzschmar, et al.
Pulmonary Circulation|May 11, 2016
Effects of age and sex on the pharmacokinetics of the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)Reiner Frey, Soundos Saleh, Corina Becker, et al.
Pulmonary Circulation|May 11, 2016
Population pharmacokinetics and the pharmacokinetic/pharmacodynamic relationship of riociguat in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertensionSoundos Saleh, Corina Becker, Reiner Frey, et al.
Pulmonary Circulation|June 3, 2016
Current concepts in the pathogenesis of chronic thromboembolic pulmonary hypertensionDaniel T Matthews, Anna R Hemnes
Pulmonary Circulation|June 3, 2016
Proline-rich tyrosine kinase 2 downregulates peroxisome proliferator-activated receptor gamma to promote hypoxia-induced pulmonary artery smooth muscle cell proliferationKaiser M Bijli, Bum-Yong Kang, Roy L Sutliff, et al.
Pulmonary Circulation|June 3, 2016
Antagonism of the thromboxane-prostanoid receptor is cardioprotective against right ventricular pressure overloadJames D West, Bryan M Voss, Leo Pavliv, et al.
Pageof 181